Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Amiral

Showing results (61-70 of 116) with videos related to

Pageof 12
Sort By:
Blood|May 9, 2001
Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopeniaC Pouplard, S Iochmann, B Renard, et al.
British Journal of Haematology|January 1, 1996
Carboxy-terminal peptides (C1-24 and C13-24 but not C1-13) of platelet factor 4 inhibit murine megakaryocytopoiesis, an activity which is neutralized by heparinI Lebeurier, N Basara, S Aïdoudi, et al.
American Journal of Hematology|June 1, 1996
Generation of antibodies to heparin-PF4 complexes without thrombocytopenia in patients treated with unfractionated or low-molecular-weight heparinJ Amiral, E Peynaud-Debayle, M Wolf, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 18, 1998
A supersulfated low-molecular-weight heparin (IK-SSH) increases plasma levels of free and total tissue factor pathway inhibitor after intravenous and subcutaneous administration in humansB Kaiser, E Glusa, D A Hoppensteadt, et al.
La Revue De Medecine Interne|October 16, 1999
[Low prevalence of anti-annexin V antibodies in antiphospholipid syndrome with fetal loss]C Siaka, M Lambert, C Caron, et al.
American Journal of Clinical Pathology|December 1, 1995
Comparison of PF4/heparin ELISA assay with the 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopeniaG Arepally, C Reynolds, A Tomaski, et al.
The Journal of Biological Chemistry|May 5, 1988
A conserved epitope on several human vitamin K-dependent proteins. Location of the antigenic site and influence of metal ions on antibody bindingW R Church, T Messier, P R Howard, et al.
European Journal of Clinical Investigation|June 1, 1991
Involvement of heparin cofactor II in chymotrypsin neutralization and in the pancreatic proteinase-antiproteinase interaction during acute pancreatitis in manP Toulon, G Chadeuf, J L Bouillot, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|September 25, 1998
Localisation of protein Z in vascular lesions of patients with atherosclerosisJ Greten, I Kreis, B Liliensiek, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 1, 1994
Clinical applications of a direct assay of free protein S antigen using monoclonal antibodies. A study of 59 casesM Wolf, C Boyer-Neumann, E Peynaud-Debayle, et al.
Pageof 12

Showing results (61-70 of 116) with videos related to

Sort By:
Pageof 12
Blood|May 9, 2001
Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopeniaC Pouplard, S Iochmann, B Renard, et al.
British Journal of Haematology|January 1, 1996
Carboxy-terminal peptides (C1-24 and C13-24 but not C1-13) of platelet factor 4 inhibit murine megakaryocytopoiesis, an activity which is neutralized by heparinI Lebeurier, N Basara, S Aïdoudi, et al.
American Journal of Hematology|June 1, 1996
Generation of antibodies to heparin-PF4 complexes without thrombocytopenia in patients treated with unfractionated or low-molecular-weight heparinJ Amiral, E Peynaud-Debayle, M Wolf, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 18, 1998
A supersulfated low-molecular-weight heparin (IK-SSH) increases plasma levels of free and total tissue factor pathway inhibitor after intravenous and subcutaneous administration in humansB Kaiser, E Glusa, D A Hoppensteadt, et al.
La Revue De Medecine Interne|October 16, 1999
[Low prevalence of anti-annexin V antibodies in antiphospholipid syndrome with fetal loss]C Siaka, M Lambert, C Caron, et al.
American Journal of Clinical Pathology|December 1, 1995
Comparison of PF4/heparin ELISA assay with the 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopeniaG Arepally, C Reynolds, A Tomaski, et al.
The Journal of Biological Chemistry|May 5, 1988
A conserved epitope on several human vitamin K-dependent proteins. Location of the antigenic site and influence of metal ions on antibody bindingW R Church, T Messier, P R Howard, et al.
European Journal of Clinical Investigation|June 1, 1991
Involvement of heparin cofactor II in chymotrypsin neutralization and in the pancreatic proteinase-antiproteinase interaction during acute pancreatitis in manP Toulon, G Chadeuf, J L Bouillot, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|September 25, 1998
Localisation of protein Z in vascular lesions of patients with atherosclerosisJ Greten, I Kreis, B Liliensiek, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 1, 1994
Clinical applications of a direct assay of free protein S antigen using monoclonal antibodies. A study of 59 casesM Wolf, C Boyer-Neumann, E Peynaud-Debayle, et al.
Pageof 12